Supplementary Figure S1 from TR-107, an Agonist of Caseinolytic Peptidase Proteolytic Subunit, Disrupts Mitochondrial Metabolism and Inhibits the Growth of Human Colorectal Cancer Cells Article Swipe
Michael Giarrizzo
,
Joseph F. LaComb
,
Hetvi R. Patel
,
Rohan G. Reddy
,
John D. Haley
,
Lee M. Graves
,
Edwin J. Iwanowicz
,
Agnieszka B. Bialkowska
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1535-7163.27950904
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1535-7163.27950904
Supplementary Figure S1. Assessment of IC50 of TR-107 in NIH 3T3 cells. (A) NIH 3T3 cells were treated with vehicle control (0.1% DMSO) or various log-fold concentrations of TR-107 as described in Materials and Methods. CellTiter-Glo cell viability assay was performed 72 hours post-treatment. IC50 values (nmol/L) were calculated with GraphPad Prism and listed on each respective graph. Data are presented as mean ± SD (N=6).
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1535-7163.27950904
- https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_TR-107_an_Agonist_of_Caseinolytic_Peptidase_Proteolytic_Subunit_Disrupts_Mitochondrial_Metabolism_and_Inhibits_the_Growth_of_Human_Colorectal_Cancer_Cells/27950904/1/files/50939505.pdf
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4404976702
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4404976702Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1535-7163.27950904Digital Object Identifier
- Title
-
Supplementary Figure S1 from TR-107, an Agonist of Caseinolytic Peptidase Proteolytic Subunit, Disrupts Mitochondrial Metabolism and Inhibits the Growth of Human Colorectal Cancer CellsWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-12-03Full publication date if available
- Authors
-
Michael Giarrizzo, Joseph F. LaComb, Hetvi R. Patel, Rohan G. Reddy, John D. Haley, Lee M. Graves, Edwin J. Iwanowicz, Agnieszka B. BialkowskaList of authors in order
- Landing page
-
https://doi.org/10.1158/1535-7163.27950904Publisher landing page
- PDF URL
-
https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_TR-107_an_Agonist_of_Caseinolytic_Peptidase_Proteolytic_Subunit_Disrupts_Mitochondrial_Metabolism_and_Inhibits_the_Growth_of_Human_Colorectal_Cancer_Cells/27950904/1/files/50939505.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_TR-107_an_Agonist_of_Caseinolytic_Peptidase_Proteolytic_Subunit_Disrupts_Mitochondrial_Metabolism_and_Inhibits_the_Growth_of_Human_Colorectal_Cancer_Cells/27950904/1/files/50939505.pdfDirect OA link when available
- Concepts
-
IC50, Viability assay, Molecular biology, Metabolism, Chemistry, Cell, Biology, Biochemistry, In vitroTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4404976702 |
|---|---|
| doi | https://doi.org/10.1158/1535-7163.27950904 |
| ids.doi | https://doi.org/10.1158/1535-7163.27950904 |
| ids.openalex | https://openalex.org/W4404976702 |
| fwci | |
| type | preprint |
| title | Supplementary Figure S1 from TR-107, an Agonist of Caseinolytic Peptidase Proteolytic Subunit, Disrupts Mitochondrial Metabolism and Inhibits the Growth of Human Colorectal Cancer Cells |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T12505 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9417999982833862 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Peptidase Inhibition and Analysis |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777752497 |
| concepts[0].level | 3 |
| concepts[0].score | 0.5874887704849243 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q286779 |
| concepts[0].display_name | IC50 |
| concepts[1].id | https://openalex.org/C53227056 |
| concepts[1].level | 3 |
| concepts[1].score | 0.5069501399993896 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q189152 |
| concepts[1].display_name | Viability assay |
| concepts[2].id | https://openalex.org/C153911025 |
| concepts[2].level | 1 |
| concepts[2].score | 0.4902644455432892 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q7202 |
| concepts[2].display_name | Molecular biology |
| concepts[3].id | https://openalex.org/C62231903 |
| concepts[3].level | 2 |
| concepts[3].score | 0.4245275557041168 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1057 |
| concepts[3].display_name | Metabolism |
| concepts[4].id | https://openalex.org/C185592680 |
| concepts[4].level | 0 |
| concepts[4].score | 0.4198247194290161 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[4].display_name | Chemistry |
| concepts[5].id | https://openalex.org/C1491633281 |
| concepts[5].level | 2 |
| concepts[5].score | 0.3892447352409363 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7868 |
| concepts[5].display_name | Cell |
| concepts[6].id | https://openalex.org/C86803240 |
| concepts[6].level | 0 |
| concepts[6].score | 0.31346410512924194 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[6].display_name | Biology |
| concepts[7].id | https://openalex.org/C55493867 |
| concepts[7].level | 1 |
| concepts[7].score | 0.3058912754058838 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[7].display_name | Biochemistry |
| concepts[8].id | https://openalex.org/C202751555 |
| concepts[8].level | 2 |
| concepts[8].score | 0.2111750841140747 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[8].display_name | In vitro |
| keywords[0].id | https://openalex.org/keywords/ic50 |
| keywords[0].score | 0.5874887704849243 |
| keywords[0].display_name | IC50 |
| keywords[1].id | https://openalex.org/keywords/viability-assay |
| keywords[1].score | 0.5069501399993896 |
| keywords[1].display_name | Viability assay |
| keywords[2].id | https://openalex.org/keywords/molecular-biology |
| keywords[2].score | 0.4902644455432892 |
| keywords[2].display_name | Molecular biology |
| keywords[3].id | https://openalex.org/keywords/metabolism |
| keywords[3].score | 0.4245275557041168 |
| keywords[3].display_name | Metabolism |
| keywords[4].id | https://openalex.org/keywords/chemistry |
| keywords[4].score | 0.4198247194290161 |
| keywords[4].display_name | Chemistry |
| keywords[5].id | https://openalex.org/keywords/cell |
| keywords[5].score | 0.3892447352409363 |
| keywords[5].display_name | Cell |
| keywords[6].id | https://openalex.org/keywords/biology |
| keywords[6].score | 0.31346410512924194 |
| keywords[6].display_name | Biology |
| keywords[7].id | https://openalex.org/keywords/biochemistry |
| keywords[7].score | 0.3058912754058838 |
| keywords[7].display_name | Biochemistry |
| keywords[8].id | https://openalex.org/keywords/in-vitro |
| keywords[8].score | 0.2111750841140747 |
| keywords[8].display_name | In vitro |
| language | en |
| locations[0].id | doi:10.1158/1535-7163.27950904 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_TR-107_an_Agonist_of_Caseinolytic_Peptidase_Proteolytic_Subunit_Disrupts_Mitochondrial_Metabolism_and_Inhibits_the_Growth_of_Human_Colorectal_Cancer_Cells/27950904/1/files/50939505.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1535-7163.27950904 |
| locations[1].id | pmh:oai:figshare.com:article/27950904 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_TR-107_an_Agonist_of_Caseinolytic_Peptidase_Proteolytic_Subunit_Disrupts_Mitochondrial_Metabolism_and_Inhibits_the_Growth_of_Human_Colorectal_Cancer_Cells/27950904 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5036014275 |
| authorships[0].author.orcid | https://orcid.org/0009-0006-3663-447X |
| authorships[0].author.display_name | Michael Giarrizzo |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Michael Giarrizzo |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5103031666 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2981-1072 |
| authorships[1].author.display_name | Joseph F. LaComb |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Joseph F. LaComb |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5027989581 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Hetvi R. Patel |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Hetvi R. Patel |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5038128668 |
| authorships[3].author.orcid | https://orcid.org/0009-0002-1993-9459 |
| authorships[3].author.display_name | Rohan G. Reddy |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Rohan G. Reddy |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5101892784 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-2652-4841 |
| authorships[4].author.display_name | John D. Haley |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | John D. Haley |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5082891287 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-4736-9855 |
| authorships[5].author.display_name | Lee M. Graves |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Lee M. Graves |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5045292739 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Edwin J. Iwanowicz |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Edwin J. Iwanowicz |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5000994247 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-2127-7714 |
| authorships[7].author.display_name | Agnieszka B. Bialkowska |
| authorships[7].author_position | last |
| authorships[7].raw_author_name | Agnieszka B. Bialkowska |
| authorships[7].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_TR-107_an_Agonist_of_Caseinolytic_Peptidase_Proteolytic_Subunit_Disrupts_Mitochondrial_Metabolism_and_Inhibits_the_Growth_of_Human_Colorectal_Cancer_Cells/27950904/1/files/50939505.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Figure S1 from TR-107, an Agonist of Caseinolytic Peptidase Proteolytic Subunit, Disrupts Mitochondrial Metabolism and Inhibits the Growth of Human Colorectal Cancer Cells |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12505 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9417999982833862 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Peptidase Inhibition and Analysis |
| related_works | https://openalex.org/W2949991425, https://openalex.org/W4385687789, https://openalex.org/W2059634348, https://openalex.org/W2377741953, https://openalex.org/W3160550515, https://openalex.org/W4224437047, https://openalex.org/W3164376613, https://openalex.org/W2379809923, https://openalex.org/W4367186701, https://openalex.org/W4232240465 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1535-7163.27950904 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_TR-107_an_Agonist_of_Caseinolytic_Peptidase_Proteolytic_Subunit_Disrupts_Mitochondrial_Metabolism_and_Inhibits_the_Growth_of_Human_Colorectal_Cancer_Cells/27950904/1/files/50939505.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1535-7163.27950904 |
| primary_location.id | doi:10.1158/1535-7163.27950904 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S1_from_TR-107_an_Agonist_of_Caseinolytic_Peptidase_Proteolytic_Subunit_Disrupts_Mitochondrial_Metabolism_and_Inhibits_the_Growth_of_Human_Colorectal_Cancer_Cells/27950904/1/files/50939505.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1535-7163.27950904 |
| publication_date | 2024-12-03 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.72 | 41 |
| abstract_inverted_index.SD | 64 |
| abstract_inverted_index.as | 29, 61 |
| abstract_inverted_index.in | 8, 31 |
| abstract_inverted_index.of | 4, 6, 27 |
| abstract_inverted_index.on | 54 |
| abstract_inverted_index.or | 23 |
| abstract_inverted_index.± | 63 |
| abstract_inverted_index.(A) | 12 |
| abstract_inverted_index.3T3 | 10, 14 |
| abstract_inverted_index.NIH | 9, 13 |
| abstract_inverted_index.S1. | 2 |
| abstract_inverted_index.and | 33, 52 |
| abstract_inverted_index.are | 59 |
| abstract_inverted_index.was | 39 |
| abstract_inverted_index.Data | 58 |
| abstract_inverted_index.IC50 | 5, 44 |
| abstract_inverted_index.cell | 36 |
| abstract_inverted_index.each | 55 |
| abstract_inverted_index.mean | 62 |
| abstract_inverted_index.were | 16, 47 |
| abstract_inverted_index.with | 18, 49 |
| abstract_inverted_index.(0.1% | 21 |
| abstract_inverted_index.DMSO) | 22 |
| abstract_inverted_index.Prism | 51 |
| abstract_inverted_index.assay | 38 |
| abstract_inverted_index.cells | 15 |
| abstract_inverted_index.hours | 42 |
| abstract_inverted_index.Figure | 1 |
| abstract_inverted_index.TR-107 | 7, 28 |
| abstract_inverted_index.cells. | 11 |
| abstract_inverted_index.graph. | 57 |
| abstract_inverted_index.listed | 53 |
| abstract_inverted_index.values | 45 |
| abstract_inverted_index.control | 20 |
| abstract_inverted_index.treated | 17 |
| abstract_inverted_index.various | 24 |
| abstract_inverted_index.vehicle | 19 |
| abstract_inverted_index.(nmol/L) | 46 |
| abstract_inverted_index.GraphPad | 50 |
| abstract_inverted_index.Methods. | 34 |
| abstract_inverted_index.log-fold | 25 |
| abstract_inverted_index.Materials | 32 |
| abstract_inverted_index.described | 30 |
| abstract_inverted_index.performed | 40 |
| abstract_inverted_index.presented | 60 |
| abstract_inverted_index.viability | 37 |
| abstract_inverted_index.Assessment | 3 |
| abstract_inverted_index.calculated | 48 |
| abstract_inverted_index.respective | 56 |
| abstract_inverted_index.CellTiter-Glo | 35 |
| abstract_inverted_index.concentrations | 26 |
| abstract_inverted_index.post-treatment. | 43 |
| abstract_inverted_index.<p>Supplementary | 0 |
| abstract_inverted_index.(<i>N</i>=6).</p> | 65 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 8 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8199999928474426 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.42261127 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |